Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IGC Pharma (IGC) Non-cash Items (2016 - 2018)

IGC Pharma (IGC) has disclosed Non-cash Items for 4 consecutive years, with $105884.0 as the latest value for Q1 2018.

  • Quarterly Non-cash Items changed N/A to $105884.0 in Q1 2018 from the year-ago period, while the trailing twelve-month figure was $105884.0 through Mar 2018, changed N/A year-over-year, with the annual reading at $105884.0 for FY2018, N/A changed from the prior year.
  • Non-cash Items for Q1 2018 was $105884.0 at IGC Pharma, down from $130045.0 in the prior quarter.
  • The five-year high for Non-cash Items was $130045.0 in Q2 2015, with the low at $105884.0 in Q1 2018.
  • Average Non-cash Items over 3 years is $125212.8, with a median of $130045.0 recorded in 2015.
  • Peak annual rise in Non-cash Items hit 0.0% in 2016, while the deepest fall reached 0.0% in 2016.
  • Over 3 years, Non-cash Items stood at $130045.0 in 2015, then changed by 0.0% to $130045.0 in 2016, then dropped by 18.58% to $105884.0 in 2018.
  • According to Business Quant data, Non-cash Items over the past three periods came in at $105884.0, $130045.0, and $130045.0 for Q1 2018, Q3 2016, and Q4 2015 respectively.